168 related articles for article (PubMed ID: 3048814)
1. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
Andersson R; Hansson GK; Söderström T; Jonsson R; Bengtsson BA; Nordborg E
Clin Exp Immunol; 1988 Jul; 73(1):82-7. PubMed ID: 3048814
[TBL] [Abstract][Full Text] [Related]
2. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.
Andersson R; Jonsson R; Tarkowski A; Bengtsson BA; Malmvall BE
Ann Rheum Dis; 1987 Dec; 46(12):915-23. PubMed ID: 2962542
[TBL] [Abstract][Full Text] [Related]
3. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.
Wagner AD; Goronzy JJ; Weyand CM
J Clin Invest; 1994 Sep; 94(3):1134-40. PubMed ID: 8083354
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T lymphocyte subset in giant cell arteritis and related disorders.
Elling P; Olsson A; Elling H
J Rheumatol; 1990 Feb; 17(2):225-7. PubMed ID: 2138673
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.
Cid MC; Campo E; Ercilla G; Palacin A; Vilaseca J; Villalta J; Ingelmo M
Arthritis Rheum; 1989 Jul; 32(7):884-93. PubMed ID: 2787641
[TBL] [Abstract][Full Text] [Related]
6. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2010 Mar; 117(3):628-36. PubMed ID: 20036012
[TBL] [Abstract][Full Text] [Related]
7. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Malmsjö M; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2009 May; 116(5):990-6. PubMed ID: 19410957
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-specific expression of p53 and p21 in giant cell arteritis.
Nordborg C; Aman P; Persson M; Nordborg E
APMIS; 2005 Sep; 113(9):594-9. PubMed ID: 16218934
[TBL] [Abstract][Full Text] [Related]
9. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
10. Giant cell arteritis as an antigen-driven disease.
Weyand CM; Goronzy JJ
Rheum Dis Clin North Am; 1995 Nov; 21(4):1027-39. PubMed ID: 8592735
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes.
Martinez-Taboada V; Brack A; Hunder GG; Goronzy JJ; Weyand CM
J Rheumatol; 1996 Jun; 23(6):1011-4. PubMed ID: 8782132
[TBL] [Abstract][Full Text] [Related]
12. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
[TBL] [Abstract][Full Text] [Related]
13. Giant cell vasculitis is a T cell-dependent disease.
Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
[TBL] [Abstract][Full Text] [Related]
14. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
Tsuchiya N; Mitamura T; Goto M; Moroi Y; Kinoshita M; Yokohari R; Miyamoto T
J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
[TBL] [Abstract][Full Text] [Related]
15. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of lesions of temporal arteritis in Horton's disease].
Liozon F; Lavignac C; Emilie D; Liozon E; Crevon MC; Vidal E; Bordessoule D; Catanzano G; Galanaud P
Ann Med Interne (Paris); 1993; 144(2):85-91. PubMed ID: 8333665
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies.
Schrøder HD; Olsson T; Solders G; Kristensson K; Link H
Muscle Nerve; 1988 Aug; 11(8):864-70. PubMed ID: 3262825
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
Ly KH; Régent A; Tamby MC; Mouthon L
Autoimmun Rev; 2010 Aug; 9(10):635-45. PubMed ID: 20457278
[TBL] [Abstract][Full Text] [Related]
20. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
